Neisseria zalophi
DSM 102031
Name:
Neisseria zalophi Volokhov et al. 2018
DSM No.:
102031, Type strain dsm-102031 dsm102031 dsm 102031 Neisseria zalophi
Strain designation:
CSL 7565
Other collection no.
or WDCM no.:
or WDCM no.:
ATCC BAA2455
Isolated from:
oral swap from Californian sea lion Zalophus californianus
Country:
United States of America
California, Sausalito, Marine Mammal Center facilities
California, Sausalito, Marine Mammal Center facilities
Date of sampling:
20-12-2008
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- D. V. Volokhov, U.S. Food and Drug Administration (FDA), Washington, D.C., USA; CSL 7565
Genbank accession numbers:
16S rRNA gene: FJ876273
Cultivation conditions:
Summary and
additional information:
additional information:
<- D. V. Volokhov, U.S. Food and Drug Administration (FDA), Washington, D.C., USA; CSL 7565. Oral swap from Californian sea lion Zalophus californianus. United States of America, California, Sausalito, Marine Mammal Center facilities. Sampling Date: 20.12.2008. Taxonomy/description (30178, 31948). Sequence accession no. 16S rRNA gene: FJ876273.
additional strains of this species are CSL7640 and CSL7624 (Volokhov et al. 2018)
. (Medium 215 or Medium 693, 37°C)Risk group:
1 (provisional classification by DSMZ)
Supplied as:
Delivery form | Prices | ||
Freeze Dried | 100,- € | ||
Active culture on request | 240,- € | ||
DNA | 150,- € | ||
Price Category for this culture: 1 |
Freight and handling charges will be added. See price list.
Other cultures: